These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 9715511)
1. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies. Mitsumori K; Koizumi H; Nomura T; Yamamoto S Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511 [TBL] [Abstract][Full Text] [Related]
2. The Tg rasH2 mouse in cancer hazard identification. Morton D; Alden CL; Roth AJ; Usui T Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467 [TBL] [Abstract][Full Text] [Related]
3. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice. Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579 [TBL] [Abstract][Full Text] [Related]
4. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice. Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063 [TBL] [Abstract][Full Text] [Related]
5. Validation of transgenic mice harboring the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Yamamoto S; Urano K; Nomura T Toxicol Lett; 1998 Dec; 102-103():473-8. PubMed ID: 10022298 [TBL] [Abstract][Full Text] [Related]
6. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing. Yamamoto S; Urano K; Koizumi H; Wakana S; Hioki K; Mitsumori K; Kurokawa Y; Hayashi Y; Nomura T Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):57-69. PubMed ID: 9539005 [TBL] [Abstract][Full Text] [Related]
7. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis. Tamaoki N Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564 [TBL] [Abstract][Full Text] [Related]
8. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice. Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969 [TBL] [Abstract][Full Text] [Related]
9. Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice. Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M Toxicol Pathol; 2002; 30(3):328-38. PubMed ID: 12051550 [TBL] [Abstract][Full Text] [Related]
10. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study. Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414 [TBL] [Abstract][Full Text] [Related]
11. Historical control data of spontaneous tumors in transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) mice. Paranjpe MG; Elbekaei RH; Shah SA; Hickman M; Wenk ML; Zahalka EA Int J Toxicol; 2013; 32(1):48-57. PubMed ID: 23324159 [TBL] [Abstract][Full Text] [Related]
12. Spontaneous tumor incidence in rasH2 mice: review of internal data and published literature. Nambiar PR; Turnquist SE; Morton D Toxicol Pathol; 2012 Jun; 40(4):614-23. PubMed ID: 22328410 [TBL] [Abstract][Full Text] [Related]
13. Susceptibility of transgenic mice carrying human prototype c-Ha-ras gene in a short-term carcinogenicity study of vinyl carbamate and ras gene analyses of the induced tumors. Mitsumori K; Wakana S; Yamamoto S; Kodama Y; Yasuhara K; Nomura T; Hayashi Y; Maronpot RR Mol Carcinog; 1997 Nov; 20(3):298-307. PubMed ID: 9397190 [TBL] [Abstract][Full Text] [Related]
14. Carcinogenic susceptibility to N-bis(2-hydroxypropyl)nitrosamine (DHPN) in rasH2 mice. Okamura M; Moto M; Kashida Y; Machida N; Mitsumori K Toxicol Pathol; 2004; 32(4):474-81. PubMed ID: 15223773 [TBL] [Abstract][Full Text] [Related]
15. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study. Toyosawa K; Okimoto K; Kobayashi I; Kijima K; Kikawa E; Kohchi M; Koujitani T; Tanaka K; Matsuoka N Toxicol Pathol; 2001; 29(4):458-66. PubMed ID: 11560251 [TBL] [Abstract][Full Text] [Related]
16. Examination of percutaneous application in a 26-week carcinogenicity test in CB6F1-TG rasH2 mice. Urano K; Suzuki S; Machida K; Eguchi N; Sawa N; Kikuchi K; Hattori Y; Usui T J Toxicol Sci; 2007 Oct; 32(4):367-75. PubMed ID: 17965551 [TBL] [Abstract][Full Text] [Related]
17. Twenty-six-week oral carcinogenicity study of 3-monochloropropane-1,2-diol in CB6F1-rasH2 transgenic mice. Lee BS; Park SJ; Kim YB; Han JS; Jeong EJ; Son HY; Moon KS Arch Toxicol; 2017 Jan; 91(1):453-464. PubMed ID: 27017489 [TBL] [Abstract][Full Text] [Related]
18. Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene. Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Mitsumori K Cancer Lett; 2000 May; 153(1-2):199-209. PubMed ID: 10779650 [TBL] [Abstract][Full Text] [Related]
19. The rasH2 mouse model for assessing carcinogenic potential of pharmaceuticals. Nambiar PR; Morton D Toxicol Pathol; 2013; 41(8):1058-67. PubMed ID: 23423820 [TBL] [Abstract][Full Text] [Related]
20. Lung Tumor Induction by 26-week Dermal Application of 1,2-Dichloroethane in CB6F1-Tg rasH2 Mice. Suguro M; Numano T; Kawabe M; Doi Y; Imai N; Mera Y; Tamano S Toxicol Pathol; 2017 Apr; 45(3):427-434. PubMed ID: 28421967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]